Fox Run Management L.L.C. lifted its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 413.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,079 shares of the technology company’s stock after acquiring an additional 5,701 shares during the period. Fox Run Management L.L.C.’s holdings in Veeva Systems were worth $1,580,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in VEEV. ING Groep NV bought a new position in Veeva Systems in the 4th quarter worth approximately $5,692,000. Cookson Peirce & Co. Inc. increased its position in Veeva Systems by 39.0% in the 4th quarter. Cookson Peirce & Co. Inc. now owns 1,275 shares of the technology company’s stock worth $285,000 after buying an additional 358 shares during the period. Pinebridge Investments LLC bought a new position in Veeva Systems in the 4th quarter worth approximately $4,191,000. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in Veeva Systems by 3.3% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 47,569 shares of the technology company’s stock worth $10,619,000 after buying an additional 1,500 shares during the period. Finally, WINTON GROUP Ltd bought a new position in Veeva Systems in the 4th quarter worth approximately $3,916,000. 88.20% of the stock is owned by institutional investors.
Insider Buying and Selling
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the company’s stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the sale, the director directly owned 3,253 shares in the company, valued at $506,296.92. This represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Read Our Latest Report on VEEV
Veeva Systems Trading Down 3.1%
VEEV opened at $167.33 on Tuesday. The stock has a market cap of $27.33 billion, a PE ratio of 29.83, a P/E/G ratio of 0.76 and a beta of 0.95. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $310.50. The stock’s 50 day simple moving average is $165.94 and its 200-day simple moving average is $194.42.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. The business had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.89% and a net margin of 28.37%.Veeva Systems’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Equities analysts forecast that Veeva Systems Inc. will post 6.46 earnings per share for the current fiscal year.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
See Also
- Five stocks we like better than Veeva Systems
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
